Clinical Trial Update: Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemia [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating venetoclax plus azacitidine in combination with chidamide and the CAG regimen for fit, older patients with newly dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CAG regimen
• Chidamide (chidamide)
• Venclexta (venetoclax) (venetoclax)
• Vidaza (azacitidine) (azacitidine)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Newly Diagnosed Acute Myeloid Leukemia (AML), Elderly Patients | Phase 2 | Status: RECRUITING